NASDAQ: IPHA
Innate Pharma Sa Stock Ownership - Who owns Innate Pharma Sa?

Insider buying vs selling

Have Innate Pharma Sa insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IPHA insiders and whales buy or sell their stock.

IPHA Shareholders

What type of owners hold Innate Pharma Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lion Point Capital LP0.09%81,151$182.59kInstitution
Morgan Stanley0.05%43,524$97.93kInstitution
Jane Street Group LLC0.05%43,365$97.57kInstitution
Millennium Management LLC0.01%10,064$22.64kInstitution
Rhumbline Advisers0.01%4,734$10.65kInstitution
Ubs Group Ag0.00%861$1.94kInstitution
Gamma Investing LLC0.00%240$540.00Institution
Farther Finance Advisors LLC0.00%10$22.50Institution
Caitong International Asset Management Co Ltd0.00%2$4.50Institution

1 of 1

IPHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IPHA0.20%0.00%
ARCT85.46%12.98%Net Buying
NKTX61.88%38.12%Net Selling
QSI28.95%48.37%Net BuyingNet Buying
NBP11.05%12.11%Net BuyingNet Buying

Innate Pharma Sa Stock Ownership FAQ

Who owns Innate Pharma Sa?

Innate Pharma Sa (NASDAQ: IPHA) is owned by 0.20% institutional shareholders, 0.00% Innate Pharma Sa insiders, and 99.80% retail investors. Lion Point Capital LP is the largest individual Innate Pharma Sa shareholder, owning 81,151.00 shares representing 0.09% of the company. Lion Point Capital LP's Innate Pharma Sa shares are currently valued at $164.74k.

If you're new to stock investing, here's how to buy Innate Pharma Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.